USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Rosti Mepal Support B.V.

USPTO PatentsView assignee record - 14 granted patents across 0 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength.

RSS updates for this company

The verdict

According to USPTO PatentsView, Rosti ranks #20,338 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 0 technology areas.

#20,338
of 49,997 US assignees by volume
1st percentile
by Innovation Score (9.9/100)
1.0
avg claims per patent
-100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20338 · Foreign Corporation #20,338 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-UNK · INNOV-LOW · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-DROP · BOOK-RICH

  • GRANTS-MICRO 14 grants
  • MID-PACK #20,338/49,997
  • PHOTO-FINISH Revolutionary…
  • CPC-UNK CPC blank
  • INNOV-LOW 9.9/100
  • CLAIMS-SPARSE 1.0 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -100% vel
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Revolutionary Medical Devices, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Rosti’s 9.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Rosti

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Rosti's Innovation Score is 9.9/100 (1st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Rosti?

Each dot is one of Rosti’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Rosti’s own 1.0 claims/patent is at or below the 7.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Rosti vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 13.913.91414.1 0510152025 Granted patents (volume) Avg claims / patent Revolutionary Medical Devices, Inc. - 14, 6.93Revolutionary Med…Ricardo UK Limited - 14, 16Ricardo UKRightline Equipment, Inc. - 14, 18.36Rightline Equipme…Rosendin Electric, Inc. - 14, 19.64Rosendin ElectricRubicon Technologies Holdings, LLC - 14, 17.71Rubicon HoldingsRusoh, Inc. - 14, 4.14RusohS1core LLC - 14, 1S1coreS2W Inc. - 14, 7.71S2WRosti Mepal Support B.V. - 14, 1Rosti Mepal Suppo…
Rosti vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Rosti's grants concentrate

Rosti Mepal Support B.V. is a focused PatentsView assignee: 0 CPC subclasses . Peak complete grant year is 2017 (4 grants) versus a trough of 1 in 2019. By volume, Rosti sits between Revolutionary Medical Devices, Inc. and S2W Inc..

Who files at Rosti's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Rosti holds 14 patents at rank #20,343, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Rosti

By rank, the assignees closest to #20,343 in granted patent volume.

Rosti's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

10 1st percentile higher than 1% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 20152016201720182019 1
USPTO utility patent grants by year · 2015–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Rosti Mepal Support B.V. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 14.3%
2016 3 21.4%
2017 4 28.6%
2018 4 28.6%
2019 1 7.1%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Rosti Mepal Support B.V.'s patent record in context - here's where to go next.

  • Ranked #20,338 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Rosti Mepal Support B.V. against Revolutionary Medical Devices, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 9.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.